Cargando…

CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells

A transmembrane protein CD133 has been implicated as a marker of stem-like glioma cells and predictor for therapeutic response in malignant brain tumours. CD133 expression is commonly evaluated by using antibodies specific for the AC133 epitope located in one of the extracellular domains of membrane...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barrantes-Freer, Alonso, Renovanz, Mirjam, Eich, Marcus, Braukmann, Alina, Sprang, Bettina, Spirin, Pavel, Pardo, Luis A., Giese, Alf, Kim, Ella L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4472699/ https://www.ncbi.nlm.nih.gov/pubmed/26086074 http://dx.doi.org/10.1371/journal.pone.0130519

Ejemplares similares

Monoclonal Antibodies 13A4 and AC133 Do Not Recognize the Canine Ortholog of Mouse and Human Stem Cell Antigen Prominin-1 (CD133)
por: Thamm, Kristina, et al.
Publicado: (2016)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

$\beta$ decay of $^{133}$In : $\gamma$ emission from neutron-unbound states in $^{133}$Sn
por: Piersa, M., et al.
Publicado: (2019)

Neutron unbound single particle states in $^{133}$Sn from the beta decay of $^{133}$In
por: Flores, Miguel Madurga, et al.
Publicado: (2016)

133rd SPSC Meeting
Publicado: (2019)

133rd LHCC Meeting
Publicado: (2018)

Nuclear spectroscopy at $^{133}$Sn
por: Hoff, P, et al.
Publicado: (2000)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013)

Minutes of the 133rd Meeting of the LHCC
por: CERN. Geneva. The LHC experiments Committee
Publicado: (2018)

Colloquium No. 133 of the International Astronomical Union
por: Švestka, Zdeněk, et al.
Publicado: (1992)

$\beta$-delayed neutron spectroscopy of $^{133}$In
por: Xu, Z.Y., et al.
Publicado: (2023)

Single-particle states in $^{133}$Sn
por: Baumann, P, et al.
Publicado: (1993)

Single-Particle States in $^{133}$Sn
por: Jonson, B N G, et al.
Publicado: (2002)

Single-seutron states in 133Sn
por: Hoff, P, et al.
Publicado: (1996)

An introduction to G-functions (AM-133)
por: Dwork, Bernard, et al.
Publicado: (1994)

MON-133 Hyponatremia in Hospital Care
por: Durkan, Maeve Catherine, et al.
Publicado: (2020)

CD133 Role in Oral Carcinogenesis
por: Luna, Ealber Carvalho Macedo, et al.
Publicado: (2020)

Health Tract, No. 133: Life Wasted
Publicado: (1863)

Health Tract, No. 133: Life Wasted
Publicado: (1865)

Expressions and clinical significances of CD133 protein and CD133 mRNA in primary lesion of gastric adenocacinoma
por: Yu, Ji-wei, et al.
Publicado: (2010)

Human Glioma–Initiating Cells Show a Distinct Immature Phenotype Resembling but Not Identical to NG2 Glia
por: Barrantes-Freer, Alonso, et al.
Publicado: (2013)

AC133+ progenitor cells as gene delivery vehicle and cellular probe in subcutaneous tumor models: a preliminary study
por: Rad, Ali M, et al.
Publicado: (2009)

First In Vivo and Phantom Imaging of Cyclotron-Produced (133)La as a Theranostic Radionuclide for (225)Ac and (135)La
por: Nelson, Bryce J.B., et al.
Publicado: (2022)

MGMT promoter methylation determined by HRM in comparison to MSP and pyrosequencing for predicting high-grade glioma response
por: Switzeny, Olivier J., et al.
Publicado: (2016)

Investigation of Low-lying States in $^{133}$Sn Populated in the $\beta $ Decay of $^{133}$In Using Isomer-selective Laser Ionization
por: Piersa, M., et al.
Publicado: (2018)

Deletion 22q13.3 syndrome
por: Phelan, Mary C
Publicado: (2008)

Memorandum: request for additional beam time for S133
por: Birman, A, et al.
Publicado: (1974)

CD133 antigen expression in ovarian cancer
por: Ferrandina, Gabriella, et al.
Publicado: (2009)

Memorandum: proposal P-93 (78-133)
por: CERN. Geneva. SPS Experiments Committee
Publicado: (1978)

Proposal for a reorientation and extension of experiment T 133
por: CERN. Geneva. Track Chamber Committee
Publicado: (1969)

CD133, Selectively Targeting the Root of Cancer
por: Schmohl, Jörg U., et al.
Publicado: (2016)

MicroRNA-133a and Myocardial Infarction
por: Xiao, Yi, et al.
Publicado: (2019)

CD133 in brain tumor: the prognostic factor
por: Li, Bin, et al.
Publicado: (2016)

M133. DISCRIMINATION PHENOMENA AND THE LEVEL OF SCHIZOTYPY
por: Pignon, Baptiste, et al.
Publicado: (2020)

A133 EVALUATION OF DYSPHAGIA IN AN ACADEMIC CENTRE
por: Reed, D E, et al.
Publicado: (2022)

The Roles of MicroRNA-133 in Gynecological Tumors
por: Zhou, Yang, et al.
Publicado: (2022)

THE CD133-POSITIVE COLON CANCER CELL PHENOTYPE IS MORE INTERACTIVE WITH THE TUMOR MICROENVIRONMENT COMPARED TO CD133-NEGATIVE CELL
por: Chao, Celia, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_83rm1fmhgii61vrgl6n9vu1mbk